Contract Services
Samsung Biologics releases 2023 ESG Report
Samsung Biologics (KRX: 207940), a global contract development and manufacturing organization (CDMO), today released its 2023 Environmental, Social an...
July 19, 2023 | News
WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturing Line at Wuxi City Site
The new HP injectable manufacturing line meets Occupational Exposure Limits (OEL) as low as 10 ng/m3 and utilizes fully enclosed isolation systems and...
July 18, 2023 | News
Meissa Vaccines Signs CGMP Manufacturing Agreement for Pediatric RSV Vaccine in Phase 2 Trials
Under the agreement, Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under Current Good Manufacturing Practice (CGMP) regulations to ...
July 06, 2023 | News
Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership
As leaders in their respective fields, this strategic partnership marks an important milestone in both companies' business growth and development. Also, it...
June 28, 2023 | News
Vetter again demonstrates industry leadership in sustainability initiatives
Report now includes Scope 3 emissions Employee-driven social responsibility takes precedence as driving force for sustainability activities&...
June 14, 2023 | News
Corning and SGD Pharma Form Joint Venture for Glass Tubing Facility and Corning® Velocity® Vial Technology in India
Corning Incorporated (NYSE:GLW) and SGD Pharma today announced a joint venture that includes the opening of a new glass tubing facility to expan...
June 09, 2023 | News
Samsung Biologics Hastens Timeline for New Plant, Aiming for April 2025 Launch
Samsung Biologics will maintain the world's largest biomanufacturing capacity at 784,000 liters upon completion of the newest plant- Key features of Plant ...
June 07, 2023 | News
WuXi Biologics to Increase Manufacturing Capacity in Germany
- The investment promotes the creation of additional high-skilled jobs - As part of WuXi Biologics' global manufacturing network, a new drug p...
June 02, 2023 | News
Catalent Enhances Cryogenic Capabilities in Japan Facility for Cell and Gene Therapy Development
State-of-the-art cryogenic freezers alongside material transfer equipment have been installed that are designed to retain the integrity of investigational ...
May 25, 2023 | News
WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations
The awarded facility includes two manufacturing areas utilizing 6x1KL single-use bioreactors for perfusion and 12x4KL single-use bioreactors for fed-batch,...
May 23, 2023 | News
Australia's First End-to-End mRNA CDMO Facility to Boost Vaccine Production and Research Capabilities
What is the significance of the first end-to-end mRNA process contract development and manufacturing organization (CDMO) establishment in Australia? ...
May 17, 2023 | News
Vetter Expands Production Capacities and Services Offered at Its Austrian Site
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), continues to drive the expansion of capacities and services for the pr...
May 09, 2023 | News
Exothera Forms Partnership with Quantoom Biosciences to Launch RNA Business Unit
Exothera has partnered with Quantoom Biosciences ("Quantoom") to gain access to Quantoom’s Nfinity technology, a continuous production platform for R...
April 27, 2023 | News
Cytiva supports BioCina with first GMP production and development facility for mRNA in Australia
Expanded facility to manufacture mRNA-based therapies and vaccines Researchers at the University of Adelaide will address the design and ma...
April 26, 2023 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
